ARTICLE INFO

Article Type

Original Research

Authors

Mansouri   A. (1)
Zayeri   F. (*)
Baghestani   A.R. (1)
Ghorbanifar   Z. (2)
Delavar Kasmaei   H. (3)
Sheidaei   A. (1)






(*) “Proteomics Research Center” and “Department of Biostatistics, Faculty of Paramedical Sciences”, Shahid Beheshti University of Medical Sciences, Tehran, Iran
(1) Biostatistics Department, Paramedical Sciences Faculty, Shahid Beheshti University of Medical Sciences, Tehran, Iran
(2) Traditional Medicine Department, Shahid Beheshti University of Medical Sciences, Tehran, Iran
(3) Neurology Department, Medicine Faculty, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Correspondence

Address: Department of Biostatistics, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Qods Square, Darband Street, Tehran, Iran. Postal Code: 1971653313
Phone: +982122707347
Fax: +982122707347
fzayeri@gmail.com

Article History

Received:  March  5, 2015
Accepted:  May 22, 2015
ePublished:  June 20, 2015

BRIEF TEXT


… [1-13] Herbal medicine is effective in treatment of different types of headache [14]. … [15] Coriandrum sativism L fruit has been reported as effective in the treatment of headache [16]. Analgesic, anti-inflammatory and sedative effect of coriander has been investigated compared to other medications such as morphine and aspirin and confirmed in many animal and human studies. Substances such as linalool in coriander cause anti-inflammatory and analgesic effects.

Coriander reduces nitric acid production and increases noradrenaline and serotonin production, leading to pain decrease [17-22]. So far, no study has been done on the effect of the fruit of this plant on migraine headaches.

This study aimed to investigate the effect of Coriander fruit on migraine attack severity and duration reduction.

This is a randomized controlled clinical triple blind trial study.

All patients aged 18 to 45years who had referred to neurological clinic of Tajrish Shohada Hospital in Tehran (Iran) in 2013 due to the headache complaint, visited by a neurologist physician, were studied in case of migraine diagnosis.

After determining the sample size using sample size determination in longitudinal data formula [23], 66 patients were studied. … [24, 25]

Using 4-block method, 66 patients were divided into two groups including intervention and control groups. Subjects in intervention group received common medications as well the selected medication of coriander and control group received a conventional medication along with placebo. 15ml consumption of coriander syrup or placebo, three times a day for a month, plus 500mg daily use of sodium valproate and 10mg nortriptyline as common medication were the intervention. To prepare the medication, based on the pharmacopoeia, more than 70% brix sugar syrup and concentrated coriander extract ingredient were used as base and as an active material, respectively. The essence was compounded of 82% linalool compound, 6% geraniol, 5% alphapynen, 3% betapynen and 1.48% thymol. To make placebo, more than 70% brix sugar syrup was used. To make color similar to the medication, standard oral bright yellow color with oral code 10894 (Magnolia Company; Iran) was used. The patients were asked to record their weekly headache symptoms over 4 weeks, in terms of headache duration based on hour and severity of each attack on a 10-score scale in the related checklist and present it to the physician. Those who were attacked by migraine more than one time in a week reported the mean duration and the mean severity of the attacks as the migraine symptoms of that week. The current random effects and longitudinal data transitions models were used to analyze data [26-28]. Therefore, two proposed models determining the clinical effectiveness of traditional medicine of the coriander fruit on the clinical course of patients with migraine were fitted, and according to the nature of the data, the best model was chosen based on the criterion of goodness of fit. … [29-36]

Among 66 patients participating in the study, 51 patients (77.3%) were female and 15 patients (22.7%) were male. The mean age in intervention group was 33.09 ± 7.50years, and it was 31.3 ± 7.20years in control group (Table 1). Before the intervention, patients in the intervention group had more severe and longer attacks compared to control group. After starting the intervention, and over time, the intensity and duration of attacks decreased in both groups, but the reduction was significantly greater in the intervention group (Table 2). Random effects and transitions models showed different significances and coefficients. The results of the transfer model about the intensity of attacks and random effects model about the duration of the attacks indicated significant differences in the symptoms between the groups. The results of both models showed that the intervention group lost in average 4.27hours pain than control group. The mean of pain intensity in the patients in the intervention group lost in average 2.81 units (from 10) than control group. The duration and severity of attacks for each patient was dependent on the duration and severity of previous attack, respectively; that is to say the longer and more severe previous attack on anyone, the longer and more severe would be his current attack. Based on the criterion for selecting AIC model, transfer model (Markov) had the minimum AIC for the duration and severity of attacks and could be considered as the best option for the fitness of model. This model could introduce the relationship between the duration and severity of migraine attacks over time better than the other models. Therefore, considering the duration and severity of attacks in the previous measurement in the model, it is important and it is better to investigate the correlation of data by taking into the account the steps already taken.

Plants such as lavender, coriander and chamomile reduce nitric oxide production and thus reduce the migraine attacks [17]. Anti-inflammatory and analgesic effects of coriander extract in mice have been shown [18, 19, 22]. Coriander products can improve sleep [37, 38]. The severity and duration of migraines in the intervention group consumed the coriander fruit syrup significantly decreased. This result is consistent with similar studies. … [39, 40]

Due to chronic nature of migraine headaches, studies with longer duration and follow-up may offer better results. Fitting a model that reflects both the true spread and explicit transmission of data can better describe the effects of the intervention.

Short duration of the intervention and follow-up was of the limitations of this study.

As a preventive treatment, coriander fruits are effective on migraine severity and duration reduction. In addition, to predict the current situation, the duration and severity of previous migraine attacks are necessary to be considered.

Staff of Paramedical School and Research Center of Shahid Beheshti University of Medical Sciences is appreciated.

There was no conflict of interest for the authors.

The main plan was confirmed by Ethics Committee for Medical Studies of Shaid Beheshti University of Medical Sciences and it was registered by IRCT with register number IRCT2012122511876N.

The study was funded by Shaid Beheshti University of Medical Sciences.

TABLES and CHARTS

Show attach file


CITIATION LINKS

[1]Balaban H, Semiz M, Şentürk IA, Kavakçı Ö, Cınar Z, Dikici A, et al. Migraine prevalence, alexithymia, and post-traumatic stress disorder among medical students in Turkey. J Headache Pain. 2012;13(6):459-67.
[2]Nazari F, Safavi M, Mahmudi M. Migraine and its relation with lifestyle in women. Pain Pract. 2010;10(3):228-34.
[3]Afshinmajd S, Davati A, Akbari F. The effects of body mass index on the treatment of the patients with migraine headaches. Iran J Neurol. 2011;10(3-4):35-8.
[4]Lipton RB, Serrano D, Holland S, Fanning KM, Reed ML, Buse DC. Barriers to the diagnosis and treatment of migraine: Effects of sex, income, and headache features. Headache. 2013;53(1):81-92.
[5]Liu R, Yu S, He M, Zhao G, Yang X, Qiao X, et al. Health-care utilization for primary headache disorders in China: A population-based door-to-door survey. J Headache Pain. 2013;14(1):47.
[6]Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2163-96.
[7]Zencirci B. Comparison of the effects of dietary factors in the management and prophylaxis of migraine. J Pain Res. 2010;3:125-30.
[8]Rasmussen BK. Epidemiology of headache. Cephalalgia. 2001;21(7):774-7.
[9]Shahbeigi S, Fereshtehnejad SM, Mohammadi N, Golmakani MM, Tadayyon S, Jalilzadeh G, et al. Epidemiology of headaches in Tehran urban area: A population-based cross-sectional study in district 8, year 2010. Neurol Sci. 2013;34(7):1157-66.
[10]Wang S-J, Chen P-K, Fuh J-L. Comorbidities of migraine. Front Neurol. 2010;1:16.
[11]Durham P, Papapetropoulos S. Biomarkers associated with migraine and their potential role in migraine management. Headache. 2013;53(8):1262-77.
[12]Tajmirriahi M, Sohelipour M, Basiri K, Shaygannejad V, Ghorbani A, Saadatnia M. The effects of sodium valproate with fish oil supplementation or alone in migraine prevention: A randomized single-blind clinical trial. Iran J Neurol. 2012;11(1):21-4.
[13]Barbanti P, Aurilia C, Egeo G, Fofi L. Migraine prophylaxis: What is new and what we need?. Neurol Sci. 2011;32 Suppl 1:S111-5.
[14]Ghorbanifar Z, Kasmaei HD, Minaei B, Rezaeizadeh H, Zayeri F. Types of nasal delivery drugs and medications in iranian traditional medicine to treatment of headache. Iran Red Crescent Med J. 2014;16(6):e15935.
[15]Pal SK, Shukla Y. Herbal medicine: Current status and the future. Asian Pac J Cancer Prev. 2003;4(4):281-8.
[16]Rahimi R, Shams Ardekani MR, Farjadmand F. Innovations and experiences of Hakim Seyed Mohammad Momen Tonekaboni in Tohfe-al Momenin. 2011;1(2):165-84. [Persian]
[17]Ansari M, Rafiee K, Fallah MS, Emamgholipour S. Migraine: Molecular basis and herbal medicine. In: Chen KS, editor. Advanced topics in neurological disorders. Rijeka, Croatia: InTECH; 2012.
[18]Batista PA, Werner MF, Oliveira EC, Burgos L, Pereira P, Brum LF, et al. The antinociceptive effect of (-)-linalool in models of chronic inflammatory and neuropathic hypersensitivity in mice. J Pain. 2010;11(11):1222-9.
[19]Heidari M, Aghili M, Soltaninezhad E. Evaluation of anti-inflammatory and analgesic effects of Coriandrum sativum extract in mice. J Qazvin Univ Med Sci. 2005;8(4):8-13. [Persian]
[20]Pathan AR, Kothawade KA, Logade MN. Anxiolytic and analgesic effect of seeds of Coriandrum sativum linn. Int J Res Pharm Chem. 2011;1(4):1087-99.
[21]Sonika G, Manubala R, Deepak J. Comparative studies on anti-inflammatory activity of Coriandrum sativum, Datura stramonium and Azadirachta indica. Asian J Exp Biol Sci. 2010;1(1):151-4.
[22]Taherian AA, Vafaei AA, Ameri J. Opiate system mediate the antinociceptive effects of Coriandrum sativum in mice. Iran J Pharm Res. 2012;11(2):679-88.
[23]Schlesselman JJ. Planning a longitudinal study: I. Sample size determination. J Chronic Dis. 1973;26(9):553-60.
[24]Fitzmaurice GM, Laird NM, Rotnitzky AG. Regression models for discrete longitudinal responses. Stat Sci. 1993;8(3):284-99.
[25]Ware JH. Linear models for the analysis of longitudinal studies. Am Stat. 1985;39(2):95-101.
[26]Funatogawa I, Funatogawa T. An autoregressive linear mixed effects model for the analysis of unequally spaced longitudinal data with dose‐modification. Stat Med. 2012;31(6):589-99.
[27]Kazemi I, Crouchley R. Modelling the initial conditions in dynamic regression models of panel data with random effects. Contrib Econ Anal. 2006;274:91-117.
[28]Mansourian M, Kazemnejad A, Kazemi I, Zayeri F, Soheilian M. Bayesian analysis of longitudinal ordered data with flexible random effects using McMC: Application to diabetic macular Edema data. J Appl Stat. 2012;39(5):1087-100.
[29]Diener HC, Limmroth V. Medication-overuse headache: A worldwide problem. Lancet Neurol. 2004;3(8):475-83.
[30]Fritsche G, Diener HC. Medication overuse headaches: What is new?. Expert opin drug saf. 2002;1(4):331-8.
[31]Gilmore B, Michael M. Treatment of acute migraine headache. Am Fam Physician. 2011;83(3):271-80.
[32]Modi S, Lowder DM. Medications for migraine prophylaxis. Am Fam Physician. 2006;73(1):72-8.
[33]Bianchi A, Salomone S, Caraci F, Pizza V, Bernardini R, D'Amato CC. Role of magnesium, coenzyme Q10, riboflavin, and vitamin B12 in migraine prophylaxis. Vitam Horm. 2004;69:297-312.
[34]Lee MS, Ernst E. Acupuncture for pain: An overview of Cochrane reviews. Chin J Integr Med. 2011;17(3):187-9.
[35]Loder E, Burch R, Rizzoli P. The 2012 AHS/AAN guidelines for prevention of episodic migraine: A summary and comparison with other recent clinical practice guidelines. Headache. 2012;52(6):930-45.
[36]Rios J, Passe MM. Evidenced‐based use of botanicals, minerals, and vitamins in the prophylactic treatment of migraines. J Am Acad Nurse Pract. 2004;16(6):251-6.
[37]Linck VM, da Silva AL, Figueiró M, Piato AL, Herrmann AP, Dupont Birck F, et al. Inhaled linalool-induced sedation in mice. Phytomedicine. 2009;16(4):303-7.
[38]Emamghoreishi M, Heidari Hamedani G. Sedative-hypnotic activity of extracts and essential oil of coriander seeds. Iran J Med Sci. 2006;31(1):22-7.
[39]Engstrøm M, Hagen K, Bjørk M, Gravdahl GB, Sand T. Sleep-related and non-sleep-related migraine: Interictal sleep quality, arousals and pain thresholds. J Headache Pain. 2013;14:68.
[40]Freedom T, Evans RW. Headache and sleep. Headache. 2013;53(8):1358-66.